aTYR PHARMA (ATYR) Other Working Capital Changes (2019 - 2020)
aTYR PHARMA's (ATYR) quarterly Other Working Capital Changes came in at -$208000.0 in Q2 2026, down 129.13% on a YoY basis from $714000.0 in Q2 2025, and down 8.9% quarter-over-quarter from -$191000.0 in Q1 2026.
Powered by 
Analysis
aTYR PHARMA (ATYR) Other Working Capital Changes (2019 - 2020) Analysis & Trends
aTYR PHARMA (ATYR) has reported Other Working Capital Changes for 13 consecutive years, with -$208000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Working Capital Changes fell 129.13% year-over-year to -$208000.0; the trailing twelve-month figure through Jun 2026 stood at -$6.3 million (down 74.52% YoY), and the FY2025 full-year result was -$7.3 million, down 230.08% from the prior year.
- Other Working Capital Changes slipped to -$208000.0 in Q2 2026 per ATYR's latest filing, from -$191000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $630000.0 in Q1 2019 and bottomed at -$184000.0 in Q3 2019.
- Historically, Other Working Capital Changes has averaged -$125500.0 across 5 years, with a median of -$199500.0 in 2026.
- The widest YoY moves for Other Working Capital Changes: up 1936.84% in 2022, down 2646.27% in 2022.
- Over 5 years, Other Working Capital Changes stood at -$3.4 million in 2022, then surged by 98.74% to -$43000.0 in 2023, then sank by 993.02% to -$470000.0 in 2024, then tumbled by 132.77% to -$1.1 million in 2025, then soared by 80.99% to -$208000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$208000.0, -$191000.0, and -$1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -53,000.00 |
| Dec 31, 2020 | -53,000.00 |
| Sep 30, 2020 | -148,000.00 |
| Sep 30, 2020 | -148,000.00 |
| Jun 30, 2020 | 58,000.00 |
| Jun 30, 2020 | 58,000.00 |
| Mar 31, 2020 | -65,000.00 |
| Mar 31, 2020 | -65,000.00 |
| Dec 31, 2019 | -144,000.00 |
| Dec 31, 2019 | -144,000.00 |
| Sep 30, 2019 | -184,000.00 |
| Sep 30, 2019 | -184,000.00 |
| Jun 30, 2019 | -94,000.00 |
| Jun 30, 2019 | -94,000.00 |
| Mar 31, 2019 | 630,000.00 |
| Mar 31, 2019 | 630,000.00 |